Skip to main content
. 2020 Nov 27;10(4):255. doi: 10.3390/jpm10040255

Figure 2.

Figure 2

Potential of CD24 as a bimodal imaging biomarker for molecular CD24-targeted therapy (AC) and radio- and fluorescent intraoperative guidance (D) with dual-labeled CD24 mAbs. A theranostic approach for personalized therapy. NO: nitric oxide, mAb: monoclonal antibody, CAR NK: chimeric antigen receptor-expressing natural killer cells, TAMs: tumor-associated macrophages, AF750: Alexa Fluor 750, AF680: Alexa Fluor 680.